These findings align with previous studies that highlight the potential of GLP-1 receptor agonists in regulating lipid metabolism [33], offering a promising therapeutic strategy for addressing lipid dysregulation in AMD. The gene discussed is GLP1R; the disease is age-related macular degeneration.